nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—POR—Doxorubicin—pancreatic cancer	0.262	0.321	CbGbCtD
Nitrofurantoin—ABCG2—Tamoxifen—pancreatic cancer	0.113	0.139	CbGbCtD
Nitrofurantoin—ABCG2—Erlotinib—pancreatic cancer	0.0963	0.118	CbGbCtD
Nitrofurantoin—ABCG2—Irinotecan—pancreatic cancer	0.087	0.106	CbGbCtD
Nitrofurantoin—ABCG2—Fluorouracil—pancreatic cancer	0.0835	0.102	CbGbCtD
Nitrofurantoin—ABCG2—Docetaxel—pancreatic cancer	0.0637	0.078	CbGbCtD
Nitrofurantoin—ABCG2—Sunitinib—pancreatic cancer	0.0634	0.0777	CbGbCtD
Nitrofurantoin—ABCG2—Doxorubicin—pancreatic cancer	0.0475	0.0582	CbGbCtD
Nitrofurantoin—Malaise—Irinotecan—pancreatic cancer	0.000352	0.00192	CcSEcCtD
Nitrofurantoin—Anaemia—Gemcitabine—pancreatic cancer	0.000351	0.00191	CcSEcCtD
Nitrofurantoin—Vertigo—Irinotecan—pancreatic cancer	0.00035	0.00191	CcSEcCtD
Nitrofurantoin—Leukopenia—Irinotecan—pancreatic cancer	0.000349	0.0019	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000347	0.00189	CcSEcCtD
Nitrofurantoin—Paraesthesia—Sunitinib—pancreatic cancer	0.000347	0.00189	CcSEcCtD
Nitrofurantoin—Anaemia—Fluorouracil—pancreatic cancer	0.000345	0.00188	CcSEcCtD
Nitrofurantoin—Dyspnoea—Sunitinib—pancreatic cancer	0.000344	0.00188	CcSEcCtD
Nitrofurantoin—Malaise—Gemcitabine—pancreatic cancer	0.000342	0.00187	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000342	0.00186	CcSEcCtD
Nitrofurantoin—Cough—Irinotecan—pancreatic cancer	0.00034	0.00186	CcSEcCtD
Nitrofurantoin—Dyspepsia—Sunitinib—pancreatic cancer	0.00034	0.00185	CcSEcCtD
Nitrofurantoin—Leukopenia—Gemcitabine—pancreatic cancer	0.00034	0.00185	CcSEcCtD
Nitrofurantoin—Renal failure—Docetaxel—pancreatic cancer	0.000339	0.00185	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000338	0.00184	CcSEcCtD
Nitrofurantoin—Decreased appetite—Sunitinib—pancreatic cancer	0.000336	0.00183	CcSEcCtD
Nitrofurantoin—Leukopenia—Fluorouracil—pancreatic cancer	0.000334	0.00182	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000333	0.00182	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000332	0.00181	CcSEcCtD
Nitrofurantoin—Cough—Gemcitabine—pancreatic cancer	0.000331	0.00181	CcSEcCtD
Nitrofurantoin—Constipation—Sunitinib—pancreatic cancer	0.00033	0.0018	CcSEcCtD
Nitrofurantoin—Discomfort—Irinotecan—pancreatic cancer	0.000328	0.00179	CcSEcCtD
Nitrofurantoin—Asthenia—Tamoxifen—pancreatic cancer	0.000324	0.00176	CcSEcCtD
Nitrofurantoin—Myalgia—Gemcitabine—pancreatic cancer	0.000323	0.00176	CcSEcCtD
Nitrofurantoin—Chest pain—Gemcitabine—pancreatic cancer	0.000323	0.00176	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Docetaxel—pancreatic cancer	0.000322	0.00176	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000321	0.00175	CcSEcCtD
Nitrofurantoin—Confusional state—Irinotecan—pancreatic cancer	0.000321	0.00175	CcSEcCtD
Nitrofurantoin—Asthenia—Erlotinib—pancreatic cancer	0.00032	0.00175	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00032	0.00174	CcSEcCtD
Nitrofurantoin—Discomfort—Gemcitabine—pancreatic cancer	0.000319	0.00174	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000318	0.00174	CcSEcCtD
Nitrofurantoin—Myalgia—Fluorouracil—pancreatic cancer	0.000318	0.00173	CcSEcCtD
Nitrofurantoin—Chest pain—Fluorouracil—pancreatic cancer	0.000318	0.00173	CcSEcCtD
Nitrofurantoin—Renal impairment—Epirubicin—pancreatic cancer	0.000317	0.00173	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000316	0.00172	CcSEcCtD
Nitrofurantoin—Discomfort—Fluorouracil—pancreatic cancer	0.000314	0.00171	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000312	0.0017	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00031	0.00169	CcSEcCtD
Nitrofurantoin—Hepatitis—Docetaxel—pancreatic cancer	0.00031	0.00169	CcSEcCtD
Nitrofurantoin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000309	0.00168	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000308	0.00168	CcSEcCtD
Nitrofurantoin—Confusional state—Fluorouracil—pancreatic cancer	0.000307	0.00168	CcSEcCtD
Nitrofurantoin—Body temperature increased—Sunitinib—pancreatic cancer	0.000305	0.00167	CcSEcCtD
Nitrofurantoin—Abdominal pain—Sunitinib—pancreatic cancer	0.000305	0.00167	CcSEcCtD
Nitrofurantoin—Diarrhoea—Erlotinib—pancreatic cancer	0.000305	0.00166	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000305	0.00166	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000303	0.00165	CcSEcCtD
Nitrofurantoin—Anorexia—Irinotecan—pancreatic cancer	0.000303	0.00165	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000298	0.00163	CcSEcCtD
Nitrofurantoin—Dizziness—Tamoxifen—pancreatic cancer	0.000298	0.00163	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000296	0.00161	CcSEcCtD
Nitrofurantoin—Anorexia—Gemcitabine—pancreatic cancer	0.000295	0.00161	CcSEcCtD
Nitrofurantoin—Dizziness—Erlotinib—pancreatic cancer	0.000295	0.00161	CcSEcCtD
Nitrofurantoin—Renal impairment—Doxorubicin—pancreatic cancer	0.000293	0.0016	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Docetaxel—pancreatic cancer	0.000293	0.0016	CcSEcCtD
Nitrofurantoin—Anorexia—Fluorouracil—pancreatic cancer	0.00029	0.00158	CcSEcCtD
Nitrofurantoin—Vomiting—Tamoxifen—pancreatic cancer	0.000287	0.00156	CcSEcCtD
Nitrofurantoin—Paraesthesia—Irinotecan—pancreatic cancer	0.000286	0.00156	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Sunitinib—pancreatic cancer	0.000285	0.00155	CcSEcCtD
Nitrofurantoin—Rash—Tamoxifen—pancreatic cancer	0.000284	0.00155	CcSEcCtD
Nitrofurantoin—Vomiting—Erlotinib—pancreatic cancer	0.000284	0.00155	CcSEcCtD
Nitrofurantoin—Dyspnoea—Irinotecan—pancreatic cancer	0.000284	0.00155	CcSEcCtD
Nitrofurantoin—Somnolence—Irinotecan—pancreatic cancer	0.000283	0.00154	CcSEcCtD
Nitrofurantoin—Headache—Tamoxifen—pancreatic cancer	0.000283	0.00154	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000282	0.00154	CcSEcCtD
Nitrofurantoin—Rash—Erlotinib—pancreatic cancer	0.000281	0.00153	CcSEcCtD
Nitrofurantoin—Dyspepsia—Irinotecan—pancreatic cancer	0.00028	0.00153	CcSEcCtD
Nitrofurantoin—Headache—Erlotinib—pancreatic cancer	0.00028	0.00152	CcSEcCtD
Nitrofurantoin—Paraesthesia—Gemcitabine—pancreatic cancer	0.000278	0.00152	CcSEcCtD
Nitrofurantoin—Chills—Docetaxel—pancreatic cancer	0.000278	0.00151	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000278	0.00151	CcSEcCtD
Nitrofurantoin—Asthenia—Sunitinib—pancreatic cancer	0.000277	0.00151	CcSEcCtD
Nitrofurantoin—Decreased appetite—Irinotecan—pancreatic cancer	0.000277	0.00151	CcSEcCtD
Nitrofurantoin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000276	0.00151	CcSEcCtD
Nitrofurantoin—Somnolence—Gemcitabine—pancreatic cancer	0.000276	0.0015	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000275	0.0015	CcSEcCtD
Nitrofurantoin—Paraesthesia—Fluorouracil—pancreatic cancer	0.000274	0.00149	CcSEcCtD
Nitrofurantoin—Alopecia—Docetaxel—pancreatic cancer	0.000274	0.00149	CcSEcCtD
Nitrofurantoin—Constipation—Irinotecan—pancreatic cancer	0.000272	0.00148	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000272	0.00148	CcSEcCtD
Nitrofurantoin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000272	0.00148	CcSEcCtD
Nitrofurantoin—Somnolence—Fluorouracil—pancreatic cancer	0.000271	0.00148	CcSEcCtD
Nitrofurantoin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000269	0.00147	CcSEcCtD
Nitrofurantoin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000268	0.00146	CcSEcCtD
Nitrofurantoin—Nausea—Tamoxifen—pancreatic cancer	0.000268	0.00146	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000268	0.00146	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000266	0.00145	CcSEcCtD
Nitrofurantoin—Constipation—Gemcitabine—pancreatic cancer	0.000265	0.00145	CcSEcCtD
Nitrofurantoin—Nausea—Erlotinib—pancreatic cancer	0.000265	0.00145	CcSEcCtD
Nitrofurantoin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000265	0.00144	CcSEcCtD
Nitrofurantoin—Diarrhoea—Sunitinib—pancreatic cancer	0.000264	0.00144	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000263	0.00143	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000262	0.00143	CcSEcCtD
Nitrofurantoin—Asthma—Epirubicin—pancreatic cancer	0.000261	0.00142	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00026	0.00142	CcSEcCtD
Nitrofurantoin—Eosinophilia—Epirubicin—pancreatic cancer	0.000258	0.00141	CcSEcCtD
Nitrofurantoin—Dizziness—Sunitinib—pancreatic cancer	0.000255	0.00139	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000255	0.00139	CcSEcCtD
Nitrofurantoin—Abdominal pain—Irinotecan—pancreatic cancer	0.000252	0.00137	CcSEcCtD
Nitrofurantoin—Body temperature increased—Irinotecan—pancreatic cancer	0.000252	0.00137	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000251	0.00137	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000251	0.00137	CcSEcCtD
Nitrofurantoin—Anaemia—Docetaxel—pancreatic cancer	0.000249	0.00136	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000246	0.00134	CcSEcCtD
Nitrofurantoin—Vomiting—Sunitinib—pancreatic cancer	0.000246	0.00134	CcSEcCtD
Nitrofurantoin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000245	0.00134	CcSEcCtD
Nitrofurantoin—Rash—Sunitinib—pancreatic cancer	0.000244	0.00133	CcSEcCtD
Nitrofurantoin—Headache—Sunitinib—pancreatic cancer	0.000242	0.00132	CcSEcCtD
Nitrofurantoin—Asthma—Doxorubicin—pancreatic cancer	0.000241	0.00132	CcSEcCtD
Nitrofurantoin—Leukopenia—Docetaxel—pancreatic cancer	0.000241	0.00132	CcSEcCtD
Nitrofurantoin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000241	0.00131	CcSEcCtD
Nitrofurantoin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000239	0.0013	CcSEcCtD
Nitrofurantoin—Cough—Docetaxel—pancreatic cancer	0.000235	0.00128	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000234	0.00128	CcSEcCtD
Nitrofurantoin—Drowsiness—Epirubicin—pancreatic cancer	0.000233	0.00127	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000231	0.00126	CcSEcCtD
Nitrofurantoin—Chest pain—Docetaxel—pancreatic cancer	0.000229	0.00125	CcSEcCtD
Nitrofurantoin—Myalgia—Docetaxel—pancreatic cancer	0.000229	0.00125	CcSEcCtD
Nitrofurantoin—Nausea—Sunitinib—pancreatic cancer	0.000229	0.00125	CcSEcCtD
Nitrofurantoin—Renal failure—Epirubicin—pancreatic cancer	0.000229	0.00125	CcSEcCtD
Nitrofurantoin—Asthenia—Irinotecan—pancreatic cancer	0.000228	0.00124	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000228	0.00124	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000224	0.00122	CcSEcCtD
Nitrofurantoin—Asthenia—Gemcitabine—pancreatic cancer	0.000222	0.00121	CcSEcCtD
Nitrofurantoin—Confusional state—Docetaxel—pancreatic cancer	0.000222	0.00121	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00022	0.0012	CcSEcCtD
Nitrofurantoin—Diarrhoea—Irinotecan—pancreatic cancer	0.000218	0.00119	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000217	0.00118	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000215	0.00117	CcSEcCtD
Nitrofurantoin—Drowsiness—Doxorubicin—pancreatic cancer	0.000215	0.00117	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000213	0.00116	CcSEcCtD
Nitrofurantoin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000212	0.00116	CcSEcCtD
Nitrofurantoin—Renal failure—Doxorubicin—pancreatic cancer	0.000212	0.00115	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000211	0.00115	CcSEcCtD
Nitrofurantoin—Dizziness—Irinotecan—pancreatic cancer	0.00021	0.00115	CcSEcCtD
Nitrofurantoin—Anorexia—Docetaxel—pancreatic cancer	0.00021	0.00114	CcSEcCtD
Nitrofurantoin—Hepatitis—Epirubicin—pancreatic cancer	0.000209	0.00114	CcSEcCtD
Nitrofurantoin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000208	0.00114	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000208	0.00113	CcSEcCtD
Nitrofurantoin—Vomiting—Irinotecan—pancreatic cancer	0.000202	0.0011	CcSEcCtD
Nitrofurantoin—Dizziness—Fluorouracil—pancreatic cancer	0.000201	0.0011	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000201	0.0011	CcSEcCtD
Nitrofurantoin—Rash—Irinotecan—pancreatic cancer	0.000201	0.00109	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.0002	0.00109	CcSEcCtD
Nitrofurantoin—Headache—Irinotecan—pancreatic cancer	0.000199	0.00109	CcSEcCtD
Nitrofurantoin—Paraesthesia—Docetaxel—pancreatic cancer	0.000197	0.00108	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000197	0.00108	CcSEcCtD
Nitrofurantoin—Vomiting—Gemcitabine—pancreatic cancer	0.000197	0.00107	CcSEcCtD
Nitrofurantoin—Dyspnoea—Docetaxel—pancreatic cancer	0.000196	0.00107	CcSEcCtD
Nitrofurantoin—Somnolence—Docetaxel—pancreatic cancer	0.000196	0.00107	CcSEcCtD
Nitrofurantoin—Rash—Gemcitabine—pancreatic cancer	0.000195	0.00107	CcSEcCtD
Nitrofurantoin—Headache—Gemcitabine—pancreatic cancer	0.000194	0.00106	CcSEcCtD
Nitrofurantoin—Vomiting—Fluorouracil—pancreatic cancer	0.000194	0.00106	CcSEcCtD
Nitrofurantoin—Dyspepsia—Docetaxel—pancreatic cancer	0.000194	0.00106	CcSEcCtD
Nitrofurantoin—Hepatitis—Doxorubicin—pancreatic cancer	0.000193	0.00105	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000192	0.00105	CcSEcCtD
Nitrofurantoin—Rash—Fluorouracil—pancreatic cancer	0.000192	0.00105	CcSEcCtD
Nitrofurantoin—Decreased appetite—Docetaxel—pancreatic cancer	0.000191	0.00104	CcSEcCtD
Nitrofurantoin—Headache—Fluorouracil—pancreatic cancer	0.000191	0.00104	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00019	0.00104	CcSEcCtD
Nitrofurantoin—Nausea—Irinotecan—pancreatic cancer	0.000189	0.00103	CcSEcCtD
Nitrofurantoin—Constipation—Docetaxel—pancreatic cancer	0.000188	0.00103	CcSEcCtD
Nitrofurantoin—Chills—Epirubicin—pancreatic cancer	0.000187	0.00102	CcSEcCtD
Nitrofurantoin—Alopecia—Epirubicin—pancreatic cancer	0.000185	0.00101	CcSEcCtD
Nitrofurantoin—Nausea—Gemcitabine—pancreatic cancer	0.000184	0.001	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000183	0.000996	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000181	0.000988	CcSEcCtD
Nitrofurantoin—Nausea—Fluorouracil—pancreatic cancer	0.000181	0.000987	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00018	0.000981	CcSEcCtD
Nitrofurantoin—Flatulence—Epirubicin—pancreatic cancer	0.000179	0.000977	CcSEcCtD
Nitrofurantoin—Abdominal pain—Docetaxel—pancreatic cancer	0.000174	0.000948	CcSEcCtD
Nitrofurantoin—Body temperature increased—Docetaxel—pancreatic cancer	0.000174	0.000948	CcSEcCtD
Nitrofurantoin—Chills—Doxorubicin—pancreatic cancer	0.000173	0.000945	CcSEcCtD
Nitrofurantoin—Alopecia—Doxorubicin—pancreatic cancer	0.000171	0.000931	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000169	0.00092	CcSEcCtD
Nitrofurantoin—Anaemia—Epirubicin—pancreatic cancer	0.000168	0.000916	CcSEcCtD
Nitrofurantoin—Flatulence—Doxorubicin—pancreatic cancer	0.000166	0.000904	CcSEcCtD
Nitrofurantoin—Malaise—Epirubicin—pancreatic cancer	0.000164	0.000894	CcSEcCtD
Nitrofurantoin—Vertigo—Epirubicin—pancreatic cancer	0.000163	0.000891	CcSEcCtD
Nitrofurantoin—Leukopenia—Epirubicin—pancreatic cancer	0.000163	0.000887	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000162	0.000884	CcSEcCtD
Nitrofurantoin—Cough—Epirubicin—pancreatic cancer	0.000159	0.000865	CcSEcCtD
Nitrofurantoin—Asthenia—Docetaxel—pancreatic cancer	0.000158	0.000861	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000156	0.000851	CcSEcCtD
Nitrofurantoin—Anaemia—Doxorubicin—pancreatic cancer	0.000155	0.000848	CcSEcCtD
Nitrofurantoin—Myalgia—Epirubicin—pancreatic cancer	0.000155	0.000844	CcSEcCtD
Nitrofurantoin—Chest pain—Epirubicin—pancreatic cancer	0.000155	0.000844	CcSEcCtD
Nitrofurantoin—Discomfort—Epirubicin—pancreatic cancer	0.000153	0.000834	CcSEcCtD
Nitrofurantoin—Malaise—Doxorubicin—pancreatic cancer	0.000152	0.000827	CcSEcCtD
Nitrofurantoin—Vertigo—Doxorubicin—pancreatic cancer	0.000151	0.000824	CcSEcCtD
Nitrofurantoin—Leukopenia—Doxorubicin—pancreatic cancer	0.000151	0.000821	CcSEcCtD
Nitrofurantoin—Diarrhoea—Docetaxel—pancreatic cancer	0.00015	0.000821	CcSEcCtD
Nitrofurantoin—Confusional state—Epirubicin—pancreatic cancer	0.00015	0.000816	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000148	0.000809	CcSEcCtD
Nitrofurantoin—Cough—Doxorubicin—pancreatic cancer	0.000147	0.0008	CcSEcCtD
Nitrofurantoin—Dizziness—Docetaxel—pancreatic cancer	0.000145	0.000793	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000145	0.000792	CcSEcCtD
Nitrofurantoin—Chest pain—Doxorubicin—pancreatic cancer	0.000143	0.000781	CcSEcCtD
Nitrofurantoin—Myalgia—Doxorubicin—pancreatic cancer	0.000143	0.000781	CcSEcCtD
Nitrofurantoin—Discomfort—Doxorubicin—pancreatic cancer	0.000141	0.000772	CcSEcCtD
Nitrofurantoin—Anorexia—Epirubicin—pancreatic cancer	0.000141	0.000771	CcSEcCtD
Nitrofurantoin—Vomiting—Docetaxel—pancreatic cancer	0.00014	0.000763	CcSEcCtD
Nitrofurantoin—Rash—Docetaxel—pancreatic cancer	0.000139	0.000756	CcSEcCtD
Nitrofurantoin—Confusional state—Doxorubicin—pancreatic cancer	0.000138	0.000755	CcSEcCtD
Nitrofurantoin—Headache—Docetaxel—pancreatic cancer	0.000138	0.000751	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000137	0.000749	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000135	0.000737	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000134	0.000733	CcSEcCtD
Nitrofurantoin—Paraesthesia—Epirubicin—pancreatic cancer	0.000133	0.000726	CcSEcCtD
Nitrofurantoin—Dyspnoea—Epirubicin—pancreatic cancer	0.000132	0.000721	CcSEcCtD
Nitrofurantoin—Somnolence—Epirubicin—pancreatic cancer	0.000132	0.000719	CcSEcCtD
Nitrofurantoin—Anorexia—Doxorubicin—pancreatic cancer	0.000131	0.000714	CcSEcCtD
Nitrofurantoin—Nausea—Docetaxel—pancreatic cancer	0.000131	0.000712	CcSEcCtD
Nitrofurantoin—Dyspepsia—Epirubicin—pancreatic cancer	0.000131	0.000712	CcSEcCtD
Nitrofurantoin—Decreased appetite—Epirubicin—pancreatic cancer	0.000129	0.000703	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000128	0.000698	CcSEcCtD
Nitrofurantoin—Constipation—Epirubicin—pancreatic cancer	0.000127	0.000692	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000125	0.000682	CcSEcCtD
Nitrofurantoin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000123	0.000672	CcSEcCtD
Nitrofurantoin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000122	0.000667	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000122	0.000667	CcSEcCtD
Nitrofurantoin—Somnolence—Doxorubicin—pancreatic cancer	0.000122	0.000665	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000121	0.000662	CcSEcCtD
Nitrofurantoin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000121	0.000659	CcSEcCtD
Nitrofurantoin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000119	0.000651	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000118	0.000646	CcSEcCtD
Nitrofurantoin—Constipation—Doxorubicin—pancreatic cancer	0.000117	0.00064	CcSEcCtD
Nitrofurantoin—Body temperature increased—Epirubicin—pancreatic cancer	0.000117	0.00064	CcSEcCtD
Nitrofurantoin—Abdominal pain—Epirubicin—pancreatic cancer	0.000117	0.00064	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000113	0.000617	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000112	0.000612	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000109	0.000596	CcSEcCtD
Nitrofurantoin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000109	0.000592	CcSEcCtD
Nitrofurantoin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000109	0.000592	CcSEcCtD
Nitrofurantoin—Asthenia—Epirubicin—pancreatic cancer	0.000106	0.00058	CcSEcCtD
Nitrofurantoin—Diarrhoea—Epirubicin—pancreatic cancer	0.000101	0.000554	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000101	0.000552	CcSEcCtD
Nitrofurantoin—Asthenia—Doxorubicin—pancreatic cancer	9.85e-05	0.000537	CcSEcCtD
Nitrofurantoin—Dizziness—Epirubicin—pancreatic cancer	9.81e-05	0.000535	CcSEcCtD
Nitrofurantoin—Vomiting—Epirubicin—pancreatic cancer	9.43e-05	0.000514	CcSEcCtD
Nitrofurantoin—Diarrhoea—Doxorubicin—pancreatic cancer	9.39e-05	0.000512	CcSEcCtD
Nitrofurantoin—Rash—Epirubicin—pancreatic cancer	9.35e-05	0.00051	CcSEcCtD
Nitrofurantoin—Headache—Epirubicin—pancreatic cancer	9.29e-05	0.000507	CcSEcCtD
Nitrofurantoin—Dizziness—Doxorubicin—pancreatic cancer	9.08e-05	0.000495	CcSEcCtD
Nitrofurantoin—Nausea—Epirubicin—pancreatic cancer	8.81e-05	0.000481	CcSEcCtD
Nitrofurantoin—Vomiting—Doxorubicin—pancreatic cancer	8.73e-05	0.000476	CcSEcCtD
Nitrofurantoin—Rash—Doxorubicin—pancreatic cancer	8.65e-05	0.000472	CcSEcCtD
Nitrofurantoin—Headache—Doxorubicin—pancreatic cancer	8.6e-05	0.000469	CcSEcCtD
Nitrofurantoin—Nausea—Doxorubicin—pancreatic cancer	8.15e-05	0.000445	CcSEcCtD
